Medical groups release framework for women's heart health from puberty to menopause
Four leading organisations have published a coordinated framework linking hormonal life stages to cardiovascular disease prevention and risk detection.

Four leading medical organisations have published a coordinated framework that ties the prevention and management of cardiovascular disease in girls and women to distinct hormonal life stages. The framework covers the period from the years around the first menstrual period through menopause and beyond. The American Heart Association, the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine jointly released three manuscripts in the journal Circulation on Monday.
The framework organises care around four hormonally defined stages. Stage 1, perimenarche, covers the transition around the first menstrual period, roughly ages 8 to 15. Stage 2, ovarian cycling, spans the years of regular ovulatory cycles, approximately ages 15 to 44. Stage 3, perimenopause, marks the transition to variable cycle length and hormonal changes, typically ages 45 to 51. Stage 4, postmenopause, begins after the final menstrual period, generally age 51 and older.
Pregnancy is treated as a modifying life event that can occur across stages and function as a biological stress test capable of revealing previously unrecognized cardiovascular risk. Pregnancy-related conditions such as hypertensive disorders, gestational diabetes, and preterm birth are linked to higher later-life cardiovascular risk. The guidance stresses the value of optimising cardiovascular health before pregnancy and of continued attention in the postpartum period.
"Heart disease and other forms of cardiovascular disease don't suddenly become relevant when we become older women," said Dr. Stacey E. Rosen, a cardiologist and former volunteer president of the American Heart Association. She described the approach as a paradigm shift in how clinicians look at women's cardiovascular and brain health. Dr. Amanda M. Perak, a pediatric cardiologist and vice chair of the collaborative writing group, said heart health for women does not start at menopause and that puberty is a big turning point.
Cardiovascular disease remains the leading cause of death among women in the United States and globally. In the United States, cardiovascular disease, including heart disease and stroke, kills more than 400,000 women each year, which is more than breast cancer, lung cancer, and chronic lung disease combined. Projections indicate the burden will rise substantially by 2050 if current trends continue. The share of women ages 20 and older living with high blood pressure in the United States could rise from about 49 per cent in 2020 to 59 per cent by 2050.
Key facts
- The framework organises care into four stages: perimenarche, ovarian cycling, perimenopause, and postmenopause.
- Cardiovascular disease kills more than 400,000 women in the United States each year.
- The framework aims to address fragmented care and identify opportunities for earlier risk detection.
Three perspectives
Neutral
Four medical organisations have released a coordinated framework linking hormonal life stages to cardiovascular disease prevention.
Positive
The new approach gives clinicians across specialties shared guidance to recognise risk earlier and act before a heart attack, stroke or heart failure event.
Negative
Cardiovascular disease remains the leading cause of death among women globally, with projections indicating the burden will rise substantially by 2050.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.
